27 June 2025
27 June 2025
Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now?
Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.
The collaboration comes after Novo Nordisk terminated a frosty Hims & Hers partnership earlier this week.
The new label changes include revised usage guidelines to estimate plaque density.
The evolving oversight landscape makes it key to maintain public trust and keep scientific integrity to the fore.
The BTD was supported by data from the DKD cohort of the Phase II 2-SUCCEED study.
The collaboration will establish a platform for leukaemia and other cancer treatments within the Middle East and Africa.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
